Synaire
Room 1406, Block B, Building 6, Chuangzhi Plaza, No. 429, Maanshan South Road, Hefei, Anhui, China
Overview
Founded in 2020, Synaire (Shanghai Jinghai Weixiang Biomaterials Co., Ltd.) combines AI, synthetic biology and biomanufacturing to build “super-cell factories” that convert non-grain biomass into lactic acid, lactide and ultimately polylactic acid (PLA) products that can be chemically recycled into rPLA. The firm controls the entire chain from raw-material sourcing to end-product recycling, giving it cost and quality advantages and enabling applications across fast-moving consumer goods, food & beverage, agriculture, 3D printing, textiles, biomedicine and high-end manufacturing. Its key technical breakthroughs include gypsum-free lactic-acid production and same-grade PLA chemical recycling, both aimed at lowering cost and environmental impact. The company has already achieved industrial-scale production and is steadily increasing capacity and market share. Synaire is recognized as a national high-tech enterprise and a Shanghai “specialized and new” SME. Proceeds from its latest financing will fund production-base expansion, next-generation technology R&D and channel development. Management is also actively preparing a follow-on B+ round to accelerate growth.
- Total raised
- $14M
- Funding rounds
- 2
- Latest round
- Series B
- Latest activity
- Jan 2026
Industries
- Manufacturing
- Medical
- Medical Device
Recent funding
Series B
Jan 2026
$14M
Team
No current team members are available.